A low postoperative nonstimulated serum thyroglobulin level does not exclude the presence of radioactive iodine avid metastatic foci in intermediate-risk differentiated …
E Robenshtok, RK Grewal, S Fish, M Sabra, RM Tuttle - Thyroid, 2013 - liebertpub.com
Background: Postsurgical thyrotropin (TSH)-stimulated serum thyroglobulin (Tg) level can be
used to predict the likelihood of finding radioactive iodine (RAI) avid metastatic foci on …
used to predict the likelihood of finding radioactive iodine (RAI) avid metastatic foci on …
[HTML][HTML] Long-term prognostic value of the response to therapy assessed by laboratory and imaging findings in patients with differentiated thyroid cancer
Simple Summary In patients with differentiated thyroid cancer (DTC), the American Thyroid
Association dynamic risk stratification system has been proposed to identify patients at …
Association dynamic risk stratification system has been proposed to identify patients at …
Clinicopathologic risk factors of radioactive iodine therapy based on response assessment in patients with differentiated thyroid cancer: a multicenter retrospective …
SY Kwon, SW Lee, EJ Kong, K Kim, BI Kim… - European Journal of …, 2020 - Springer
Purpose We investigated whether predictive clinicopathologic factors can be affected by
different response criteria and how the clinical usefulness of radioactive iodine (RAI) therapy …
different response criteria and how the clinical usefulness of radioactive iodine (RAI) therapy …
[HTML][HTML] Thyroglobulin value predict iodine-123 imaging result in differentiated thyroid cancer patients
A Campennì, RM Ruggeri, M Siracusa, D Romano… - Cancers, 2023 - mdpi.com
Simple Summary This study was prompted to assess the diagnostic performance of 123I-Dx-
WBS-SPECT/CT in the identification of incomplete structural response in the early follow-up …
WBS-SPECT/CT in the identification of incomplete structural response in the early follow-up …
[HTML][HTML] Differentiated thyroid cancer outcomes after surgery and activity-adjusted 131I theragnostics
AM Avram, N Rosculet, NH Esfandiari… - Clinical nuclear …, 2019 - journals.lww.com
Purpose The aim of this study was to determine clinical outcomes in patients with
differentiated thyroid cancer after surgery and activity-adjusted 131 I therapy informed by …
differentiated thyroid cancer after surgery and activity-adjusted 131 I therapy informed by …
[HTML][HTML] Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan
M Chao - Clinical Oncology, 2010 - Elsevier
BACKGROUND: Differentiated thyroid carcinoma (DTC) with rising thyroglobulin (Tg) level
and negative radioiodine whole body scan results has been observed in follow-up studies …
and negative radioiodine whole body scan results has been observed in follow-up studies …
Avidity and outcomes of radioiodine therapy for distant metastasis of distinct types of differentiated thyroid cancer
J Simões-Pereira, N Mourinho… - The Journal of …, 2021 - academic.oup.com
Context The recommendations for radioactive-iodine treatment (RAIT) in metastatic
differentiated thyroid cancer (DTC) are mostly based in the experience with papillary …
differentiated thyroid cancer (DTC) are mostly based in the experience with papillary …
Intermediate‐risk differentiated thyroid carcinoma patients who were surgically ablated do not need adjuvant radioiodine therapy: long‐term outcome study
S Ballal, R Soundararajan, A Garg… - Clinical …, 2016 - Wiley Online Library
Objective The mute question is whether patients with DTC of intermediate risk of recurrence,
second most common presentation, who were surgically ablated in the first place, ever …
second most common presentation, who were surgically ablated in the first place, ever …
[HTML][HTML] Prognostic Impact of Direct 131I Therapy After Detection of Biochemical Recurrence in Intermediate or High-Risk Differentiated Thyroid Cancer: A …
JF Carrillo, R Vázquez-Romo… - Frontiers in …, 2019 - frontiersin.org
Background: Patients treated for intermediate-or high-risk differentiated thyroid carcinoma
(DTC) and Thyroglobulin (TG) elevation during follow-up, require a diagnostic whole-body …
(DTC) and Thyroglobulin (TG) elevation during follow-up, require a diagnostic whole-body …
Efficacy of low radioiodine activity versus intermediate-high activity in the ablation of low-risk differentiated thyroid cancer
Purpose The aim of our study was to compare the efficacy of thyroid remnant ablation using
low (1.1 GBq) and intermediate-high radioiodine (RAI) activity (1.85–3.7 GBq) in low-risk …
low (1.1 GBq) and intermediate-high radioiodine (RAI) activity (1.85–3.7 GBq) in low-risk …